Related Experiment Videos

Tc-99m MDP uptake in a cerebral infarct

R D Low¹, R J Hicks, G Gill

¹Department of Nuclear Medicine, Repatriation General Hospital, Heidelberg, Victoria, Australia.

Clinical Nuclear Medicine

|December 1, 1992

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with 177Lu DOTATATE (LuTate).

European journal of nuclear medicine and molecular imaging·2023

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society·2022

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.

European journal of nuclear medicine and molecular imaging·2022

Outcomes of surgical versus non-surgical treatment of resectable T4a laryngeal and hypopharyngeal carcinoma.

The Journal of laryngology and otology·2022

Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region.

Asia-Pacific journal of clinical oncology·2021

Longitudinal health utilities, symptoms and toxicities in patients with ALK-rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment.

Current oncology (Toronto, Ont.)·2020

See all related articles